世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Genetic Disorders, Oncology, Personalized Medicine), By Technology (Comparative Genomic Hybridisation), By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2033
Molecular Cytogenetics Market Summary The global molecular cytogenetics market size was estimated at USD 2.40 billion in 2024 and is projected to reach USD 6.39 billion by 2033, growing at a CAG... もっと見る
SummaryMolecular Cytogenetics Market SummaryThe global molecular cytogenetics market size was estimated at USD 2.40 billion in 2024 and is projected to reach USD 6.39 billion by 2033, growing at a CAGR of 11.7% from 2025 to 2033. The market expansion is supported by the increasing use of molecular cytogenetic techniques in clinical diagnostics and research, particularly in oncology, genetic disorders, and prenatal testing. These tools offer high-resolution analysis of chromosomal abnormalities, making them essential in modern laboratory and clinical workflows. The growing application of fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and array-based methods contributes to the rising adoption of molecular cytogenetics. Expanding use in personalized medicine and technological improvements in automation and imaging continue to strengthen market demand across hospitals, academic institutions, and research centers. With the growing volume of genomic data, integrating multi-omics approaches and advancements in bioinformatics tools significantly enhances the molecular cytogenetics field. These enhancements facilitate better management, analysis, and interpretation of large genomic datasets, making it easier to discover meaningful links between chromosomal alterations and diseases. As a result, demand for molecular cytogenetics is expected to grow, with laboratories increasingly relying on these tools for both research and diagnostic applications. In December 2023, Lupin Diagnostics unveiled a new state-of-the-art Regional Reference Laboratory in Chennai, Tamil Nadu. This laboratory offers a wide range of services, including molecular diagnostics and especially cytogenetics, alongside flow cytometry, cytology, and more. This expansion enhances regional access to high-quality molecular cytogenetic testing and supports better diagnostic capabilities in southern India. Such investments by major diagnostic providers validate cytogenetics' significance in routine clinical practice and reflect growing market confidence in the technology's utility and future growth potential. Global Molecular Cytogenetics Market Report Segmentation This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global molecular cytogenetics market based on application, technology, product, end use, and region: • Application Outlook (Revenue, USD Million, 2021 - 2033) • Genetic Disorders • Oncology • Personalized Medicine • Other Applications • Technology Outlook (Revenue, USD Million, 2021 - 2033) • Comparative Genomic Hybridization o aCGH o sCGH • FISH • Immunohistochemistry • Karyotyping o Spectral o Virtual • Others • Product Outlook (Revenue, USD Million, 2021 - 2033) • Instruments • Consumables • Software & Services • End Use Outlook (Revenue, USD Million, 2021 - 2033) • Clinical & Research Laboratories • Hospitals & Path Labs • Academic Research Institutes • Pharmaceutical & Biotech Companies • Others • Regional Outlook (Revenue, USD Million, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o Japan o China o India o Australia o South Korea o Thailand • Latin America o Brazil o Argentina • Middle East & Africa o South Africa o Saudi Arabia o UAE o Kuwait Table of ContentsTable of ContentsChapter 1 Molecular Cytogenetics Market: Research Methodology And Scope 1.1 Market Segmentation And Scope 1.1.1 Segment Definitions 1.1.1.1 Application Segment 1.1.1.2 Technology Segment 1.1.1.3 Product Segment 1.1.1.4 End Use Segment 1.2 Regional Scope 1.3 Estimates And Forecast Timeline 1.4 Objectives 1.4.1 Objective - 1 1.4.2 Objective - 2 1.4.3 Objective - 3 1.5 Research Methodology 1.6 Information Procurement 1.6.1 Purchased Database 1.6.2 Gvr’s Internal Database 1.6.3 Secondary Sources 1.6.4 Primary Research 1.7 Information Or Data Analysis 1.7.1 Data Analysis Models 1.8 Market Formulation & Validation 1.9 Model Details 1.9.1 Commodity Flow Analysis 1.10 List Of Secondary Sources 1.11 List Of Abbreviations Chapter 2 Molecular Cytogenetics Market: Executive Summary 2.1 Market Outlook 2.2 Application And Technology Snapshot 2.3 Product And End Use Snapshot 2.4 Competitive Landscape Snapshot Chapter 3 Molecular Cytogenetics Market: Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Related/Ancillary Market Outlook 3.2 Market Dynamics 3.2.1 Market Drivers Analysis 3.2.1.1 Rapid Technological Advancements 3.2.1.2 Increasing Prevalence Of Genetic Disorders 3.2.1.3 Growing Application In Oncology 3.2.1.4 Increasing Demand For Personalized Medicine 3.2.2 Market Restraint Analysis 3.2.2.1 High Costs Of Testing 3.2.2.2 Lack Of Reimbursement Policies 3.3 Industry Analysis Tools 3.3.1 Porter’s Analysis 3.3.2 Pestel Analysis Chapter 4 Molecular Cytogenetics Market: Application Business Analysis 4.1 Molecular Cytogenetics Market: Application Movement Analysis 4.2 Genetic Disorders 4.2.1 Genetic Disorders Market Estimates And Forecast, 2021 - 2033 (USD Million) 4.3 Oncology 4.3.1 Oncology Market Estimates And Forecast, 2021 - 2033 (USD Million) 4.4 Personalized Medicine 4.4.1 Personalized Medicine Market Estimates And Forecast, 2021 - 2033 (USD Million) 4.5 Other Application 4.5.1 Other Application Market Estimates And Forecast, 2021 - 2033 (USD Million) Chapter 5 Molecular Cytogenetics Market: Technology Business Analysis 5.1 Molecular Cytogenetics Market: Technology Movement Analysis 5.2 Comparative Genomic Hybridisation 5.2.1 Comparative Genomic Hybridisation Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.2.2 Acgh 5.2.2.1 Acgh Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.2.3 Scgh 5.2.3.1 Scgh Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.3 Fish 5.3.1 Fish Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.4 Immunohistochemistry 5.4.1 Immunohistochemistry Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.5 Karyotyping 5.5.1 Karyotyping Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.5.2 Spectral 5.5.2.1 Spectral Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.5.3 Virtual 5.5.3.1 Virtual Market Estimates And Forecast, 2021 - 2033 (USD Million) 5.6 Others 5.6.1 Others Market Estimates And Forecast, 2021 - 2033 (USD Million) Chapter 6 Molecular Cytogenetics Market: Product Business Analysis 6.1 Molecular Cytogenetics Market: Product Movement Analysis 6.2 Instruments 6.2.1 Instruments Market Estimates And Forecast, 2021 - 2033 (USD Million) 6.3 Consumables 6.3.1 Consumables Market Estimates And Forecast, 2021 - 2033 (USD Million) 6.4 Software & Services 6.4.1 Software & Services Market Estimates And Forecast, 2021 - 2033 (USD Million) Chapter 7 Molecular Cytogenetics Market: End Use Business Analysis 7.1 Molecular Cytogenetics Market: End Use Movement Analysis 7.2 Clinical & Research Laboratories 7.2.1 Clinical & Research Laboratories Market Estimates And Forecast, 2021 - 2033 (USD Million) 7.3 Hospitals & Path Labs 7.3.1 Hospitals & Path Labs Market Estimates And Forecast, 2021 - 2033 (USD Million) 7.4 Academic Research Institutes 7.4.1 Academic Research Institutes Market Estimates And Forecast, 2021 - 2033 (USD Million) 7.5 Pharmaceutical & Biotech Companies 7.5.1 Pharmaceutical & Biotech Companies Market Estimates And Forecast, 2021 - 2033 (USD Million) 7.6 Others 7.6.1 Others Market Estimates And Forecast, 2021 - 2033 (USD Million) Chapter 7 Molecular Cytogenetics Market: Regional Business Analysis 7.1 Regional Market Snapshot 7.2 North America 7.2.1 North America Molecular Cytogenetics Market Estimates And Forecast, 2021 - 2033 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S. Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.2.2.2 Key Country Dynamics 7.2.2.3 Regulatory Framework 7.2.2.4 Reimbursement Scenario 7.2.3 Canada 7.2.3.1 Canada Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.2.3.2 Key Country Dynamics 7.2.3.3 Regulatory Framework 7.2.3.4 Reimbursement Scenario 7.3 Europe 7.3.1 Europe Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.2 UK 7.3.2.1 UK Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.2.2 Key Country Dynamics 7.3.2.3 Regulatory Framework 7.3.2.4 Reimbursement Scenario 7.3.3 Germany 7.3.3.1 Germany Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.3.2 Key Country Dynamics 7.3.3.3 Regulatory Framework 7.3.3.4 Reimbursement Scenario 7.3.4 Spain 7.3.4.1 Spain Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.4.2 Key Country Dynamics 7.3.4.3 Regulatory Framework 7.3.4.4 Reimbursement Scenario 7.3.5 France 7.3.5.1 France Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.5.2 Key Country Dynamics 7.3.5.3 Regulatory Framework 7.3.5.4 Reimbursement Scenario 7.3.6 Italy 7.3.6.1 Italy Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.6.2 Key Country Dynamics 7.3.6.3 Regulatory Framework 7.3.6.4 Reimbursement Scenario 7.3.7 Denmark 7.3.7.1 Denmark Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.7.2 Key Country Dynamics 7.3.7.3 Regulatory Framework 7.3.7.4 Reimbursement Scenario 7.3.8 Sweden 7.3.8.1 Sweden Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.8.2 Key Country Dynamics 7.3.8.3 Regulatory Framework 7.3.8.4 Reimbursement Scenario 7.3.9 Norway 7.3.9.1 Norway Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.3.9.2 Key Country Dynamics 7.3.9.3 Regulatory Framework 7.3.9.4 Reimbursement Scenario 7.4 Asia Pacific 7.4.1 Asia-Pacific Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.4.2 Japan 7.4.2.1 Japan Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.4.2.2 Key Country Dynamics 7.4.2.3 Regulatory Framework 7.4.2.4 Reimbursement Scenario 7.4.3 China 7.4.3.1 China Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.4.3.2 Key Country Dynamics 7.4.3.3 Regulatory Framework 7.4.3.4 Reimbursement Scenario 7.4.4 India 7.4.4.1 India Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.4.4.2 Key Country Dynamics 7.4.4.3 Regulatory Framework 7.4.4.4. Reimbursement Scenario 7.4.5 South Korea 7.4.5.1 South Korea Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.4.5.2 Key Country Dynamics 7.4.5.3 Regulatory Framework 7.4.5.4 Reimbursement Scenario 7.4.6 Thailand 7.4.6.1 Thailand Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.4.6.2 Key Country Dynamics 7.4.6.3 Regulatory Framework 7.4.6.4 Reimbursement Scenario 7.4.7 Australia 7.4.7.1 Australia Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.4.7.2 Key Country Dynamics 7.4.7.3 Regulatory Framework 7.4.7.4 Reimbursement Scenario 7.5 Latin America 7.5.1 Latin America Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.5.2 Brazil 7.5.2.1 Brazil Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.5.2.2 Key Country Dynamics 7.5.2.3 Regulatory Framework 7.5.2.4 Reimbursement Scenario 7.5.3 Mexico 7.5.3.1 Mexico Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.5.3.2 Key Country Dynamics 7.5.3.3 Regulatory Framework 7.5.2.4 Reimbursement Scenario 7.5.4 Argentina 7.5.4.1 Argentina Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.5.4.2 Key Country Dynamics 7.5.4.3 Regulatory Framework 7.5.4.4 Reimbursement Scenario 7.6 MEA 7.6.1 MEA Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.6.2 South Africa 7.6.2.1 South Africa Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.6.2.2 Key Country Dynamics 7.6.2.3 Regulatory Framework 7.6.2.4 Reimbursement Scenario 7.6.3 Saudi Arabia 7.6.3.1 Saudi Arabia Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.6.3.2 Key Country Dynamics 7.6.3.3 Regulatory Framework 7.6.3.4 Reimbursement Scenario 7.6.4 UAE 7.6.4.1 UAE Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.6.4.2 Key Country Dynamics 7.6.4.3 Regulatory Framework 7.6.2.4 Reimbursement Scenario 7.6.5 Kuwait 7.6.5.1 Kuwait Molecular Cytogenetics Market, 2021 - 2033 (USD Million) 7.6.5.2 Key Country Dynamics 7.6.5.3 Regulatory Framework 7.6.5.4 Reimbursement Scenario Chapter 8 Molecular Cytogenetics Market: Competitive Landscape 8.1 Company Categorization 8.2 Strategy Mapping 8.2.1 New Product Launch 8.2.2 Partnerships 8.2.3 Acquisition 8.2.4 Collaboration 8.2.5 Funding 8.3 Company Market Share Analysis, 2024 8.4 Company Profiles 8.4.1 Bioview 8.4.1.1 Company Overview 8.4.1.2 Financial Performance 8.4.1.3 Product Benchmarking 8.4.1.4 Strategic Initiatives 8.4.2 Danaher 8.4.2.1 Company Overview 8.4.2.1.1 Leica Biosystems Nussloch Gmbh 8.4.2.2 Financial Performance 8.4.2.3 Product Benchmarking 8.4.2.4 Strategic Initiatives 8.4.3 Metasystems 8.4.3.1 Company Overview 8.4.3.2 Financial Performance 8.4.3.3 Product Benchmarking 8.4.3.4 Strategic Initiatives 8.4.4 Agilent Technologies, Inc. 8.4.4.1 Company Overview 8.4.4.2 Financial Performance 8.4.4.3 Product Benchmarking 8.4.4.4 Strategic Initiatives 8.4.5 Abbott 8.4.5.1 Company Overview 8.4.5.2 Financial Performance 8.4.5.3 Product Benchmarking 8.4.5.4 Strategic Initiatives 8.4.6 Bio-Rad Laboratories, Inc. 8.4.6.1 Company Overview 8.4.6.2 Financial Performance 8.4.6.3 Product Benchmarking 8.4.6.4 Strategic Initiatives 8.4.7 Illumina, Inc. 8.4.7.1 Company Overview 8.4.7.2 Financial Performance 8.4.7.3 Product Benchmarking 8.4.7.4 Strategic Initiatives 8.4.8 Oxford Gene Technology Ip Limited 8.4.8.1 Company Overview 8.4.8.2 Financial Performance 8.4.8.3 Product Benchmarking 8.4.8.4 Strategic Initiatives 8.4.9 F. Hoffmann-La Roche Ltd 8.4.9.1 Company Overview 8.4.9.1.1 Genentech, Inc. 8.4.9.2 Financial Performance 8.4.9.4 Product Benchmarking 8.4.9.5 Strategic Initiatives 8.4.10 Perkinelmer Inc. 8.4.10.1 Company Overview 8.4.10.2 Financial Performance 8.4.10.3 Product Benchmarking 8.4.10.4 Strategic Initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（バイオ薬物）の最新刊レポート
Grand View Research社の 生物分野 での最新刊レポート
本レポートと同じKEY WORD（genetic）の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
